FDA approves Merck ' s drug for rare, deadly lung condition

Exterior view of the entrance to Merck headquarters on February 05, 2024 in Rahway, New Jersey. The Food and Drug Administration on Tuesday approved a drug from Merck designed to treat a progressive and life-threatening lung condition in a win for both the drugmaker and for patients suffering from…#merck #rahway #newjersey #winrevair #pah #keytruda #jpmorgan #chrisschott #merckchiefmedical #eliavbarr
Source: Reuters: Health - Category: Consumer Health News Source Type: news